Monitoring the Quality of Medicines – Rigaku Raman Technologies
Posted on June 3, 2014
Counterfeit pharmaceuticals are a global problem and a public health concern. Ineffective treatment, financial loss, and distrust of healthcare systems result from use of substandard medicines. Those most affected live in developing and resource-limited countries. Cost-effective analysis methods that identify substandard pharmaceuticals help protect the global supply chain. Recognised by the USP and EP, handheld Raman spectroscopy is a powerful nondestructive analytical technique used to verify the identity of counterfeit drugs.
The Rigaku Progeny™ handheld Raman analyser accurately identifies dangerous and substandard pharmaceuticals in seconds. Some handheld analytical techniques experience interference from moisture or fluorescence, preventing analysis. Progeny minimises interference issues, resulting in your ability to analyse a broader range of drugs. User access levels and adjustable settings enable control over analysis parameters, producing the most reliable and actionable results. Easy-to-use and implement, Progeny’s footprint is small, cost-effective and requires no maintenance. Completely sealed to minimise cross-contamination risks, this device is rugged enough for use in harsh environments but sensitive enough to use in the lab.
Rigaku Raman Technologies is a leading pioneer in portable and handheld Raman spectroscopy. We provide advanced analytical solutions that enable our customers to achieve rapid, accurate results, at any time and in any place.
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
